Rare diseases
Investigational molecules
Locations
Back to France1 745 clinical trials in Roubaix, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer
BelgiumStudy of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
FranceStudy of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
FranceStudy on the Safety and Effectiveness of MK-1200 for Patients with Advanced Solid Tumors
FranceStudy on the Safety and Effectiveness of Amivantamab and Capmatinib for Patients with Unresectable Metastatic Non-Small Cell Lung Cancer
FranceStudy of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant
FranceStudy of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer
FranceStudy on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes
FranceStudy on the Safety and Activity of S095029 and Pembrolizumab for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
FranceStudy of ONCOFID-P-B for Patients with Bladder Carcinoma in Situ Unresponsive to BCG Treatment
FranceStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
FranceStudy on NTLA-2002 for Adults with Hereditary Angioedema Using Ziclumeran and Lonvoguran
FranceThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for Multiple Myeloma and various forms of leukemia, including comparative studies of novel therapeutic combinations and traditional approaches.
Studies evaluating treatment effectiveness in newly diagnosed patients and those with advanced disease stages.
Innovative research exploring potential treatments for Alzheimer's disease, including studies on caffeine's effects on cognitive function in early-to-moderate stage patients.
Focus on non-pharmacological interventions and their impact on disease progression.
Clinical investigations into severe asthma management and pulmonary infections, including studies on treatment optimization and novel therapeutic approaches.
Evaluation of long-term treatment strategies and comparative medication studies.
Research examining hypertension management in patients with chronic kidney disease, along with studies on thrombo-embolic complications prevention.
Focus on optimizing treatment strategies for complex cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
